QSIAW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -46.4%
- Operating margin
- -9323.0%
- Revenue growth YoY
- -69.4%
- Dividend yield
- —
- Beta
- 3.17
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Quantum-Si incorporated
Company profileQuantum-Si Incorporated is a pioneering life sciences technology company dedicated to revolutionizing protein sequencing through its proprietary single-molecule technology and advanced quantum dot capabilities. By delivering high-throughput and cost-effective sequencing solutions, Quantum-Si aims to transform protein analysis and accelerate advancements in genomics and personalized medicine. Supported by a robust intellectual property portfolio, the company is strategically positioned to capitalize on the growing demand for innovative sequencing technologies, thus driving substantial progress…
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 29 BUSINESS PARK DRIVE, BRANFORD, CT
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer